Leonteq Securities AG’s AC Immune ACIU Stock Holding History

Leonteq Securities AG’s Portfolio ACIU Stock Details ACIU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,000	Closed	-$9.42K	–	1279
2025 Q4	$9.42K	Buy	+3,000	New	+$9.46K	﹤0.01%	1198

Other funds holding ACIU

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Leonteq Securities AG's ACIU Position: Q1 2026 in Review

Leonteq Securities AG sold out of AC Immune (ACIU) in Q1 2026, closing a stake of 3,000 shares — an estimated $9.42K sold.

Leonteq Securities AG first reported a position in ACIU in Q4 2025 and held it in 1 quarter. The position peaked at $9.42K in Q4 2025. 46 funds tracked by Wall St. Rank hold ACIU as of Q1 2026.

Leonteq Securities AG reported no remaining AC Immune position as of Q1 2026 after selling out during the quarter.
Leonteq Securities AG sold 3,000 AC Immune shares in Q1 2026, an estimated $9.42K.
Leonteq Securities AG first reported a position in AC Immune in Q4 2025 and held it in 1 quarter.
Leonteq Securities AG's AC Immune position peaked at $9.42K in Q4 2025.
46 funds tracked by Wall St. Rank held AC Immune as of Q1 2026.

Based on Leonteq Securities AG's 13F filing for Q1 2026, filed 27 Apr 2026.